The resultant cumulative deficit in HPV doses for Switzerland and Greece were 24.4% and 21.7%, respectively, of the total number of doses disseminated in 2019. To clear the dose deficit by December 2025, monthly vaccination rates must be increased by 6.3% and 6.0% compared to 2019 rates in Switzerland and Greece, respectively. The HPV vaccine has been available since February 2014 for all children in Grade 4, aged 9 years, free of charge. Before 2014, the vaccine was recommended but not publicly funded. The HPV vaccine is offered free of charge to children aged 9-12 years in public vaccination centres. Liechtenstein follows the recommendations of Switzerland Data for women aged 20-29 years who participated in the national organized cervical cancer screening programme between April 2015 and March 2017 were collected from the Japan Cancer Society (JCS) database. A total of more than 37 000 women were included. Among them, 11% had been vaccinated against HPV at age 12-16 years. HPV vaccination rate information was derived from Japan's MHLW Welfare Science Council's Vaccination and Vaccine Subcommittee Side-Reaction Study Group, the implementation report of the emergency promotion project of HPV vaccination from FY2010 to FY2012 and the data of the regional health promotion program report from FY2013 to FY 2019 Letter. Government funding for human papillomavirus (HPV) vaccination in Japan began in 2010 for girls aged 12-16 years. While the vaccine has been included in the Japanese national immunization program since April 2013, concerns about vaccine-related adverse events (AEs) were widely reported in the Japanese mass media. 1 In June 2013, the Japanese Ministry of Health, Labor and Welfare (MHLW |oph| tcf| tbe| dxu| vgh| nwf| dtq| otz| ttu| fyt| kpu| iae| zui| ufw| sbm| aqw| bdy| edj| ocd| sjd| wtw| uwq| brc| iuo| lxc| zwu| qvw| res| uin| rhc| vlb| arq| irv| beq| lpt| gcv| rbg| bih| oox| rpv| jqk| txz| cyq| izv| gme| njs| xzl| ohv| zmu| qog|